Back
LivaNova PLC Vs. Perspective Therapeutics Industry Stock Comparison
Sell
36
LIVN
LivaNova PLC
Last Price:
52.10
Seasonality Move:
7.62%
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.47
Seasonality Move:
22.12%
Sell
36
LivaNova PLC (LIVN)
is a Sell
Is LivaNova PLC a Buy, Sell or Hold?
- The current LivaNova PLC [LIVN] share price is $52.11. The Score for LIVN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- LIVN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LIVN Stock Price Chart
What is LivaNova PLC's stock price today?
-
The LivaNova PLC share price today is $52.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LIVN is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.
LIVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 53.81 | Buy |
| Chaikin Money Flow: | 249021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.62 - 52.56) | Buy |
| Bollinger Bands (100): | (47.58 - 53.18) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.72 | Sell |
| Relative Strength Index (14 RSI): | 22.27 | Sell |
| Chaikin Money Flow: | 378542 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.01 - 8.85) | Sell |
| Bollinger Bands (100): | (7.78 - 15.18) | Sell |
LIVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.83 | Buy |
| 20-day SMA: | 51.39 | Buy |
| 50-day SMA: | 52.04 | Buy |
| 200-day SMA: | 53 | Sell |
| 8-day EMA: | 51.12 | Buy |
| 20-day EMA: | 51.33 | Buy |
| 50-day EMA: | 51.46 | Buy |
| 200-day EMA: | 51.91 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.69 | Sell |
| 20-day SMA: | 4.67 | Sell |
| 50-day SMA: | 9.2 | Sell |
| 200-day SMA: | 12.39 | Sell |
| 8-day EMA: | 3.77 | Sell |
| 20-day EMA: | 5.13 | Sell |
| 50-day EMA: | 8.02 | Sell |
| 200-day EMA: | 10.44 | Sell |
LivaNova PLC Earnings Growth & LIVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.25 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
LivaNova PLC Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||